Icon (Close Menu)

Logout

License Not Renewed for UAMS’ Myeloma Institute Director

2 min read

The Arkansas State Medical Board said Thursday it would not renew the educational license of Dr. Gareth Morgan, the director of the University of Arkansas for Medical Sciences’ Myeloma Institute, until he completes a course for distressed physicians. 

The board had received a complaint that “Dr. Morgan was a bit of a disruptive physician,” said  board’s attorney, Kevin O’Dwyer of Little Rock. 

UAMS spokeswoman Leslie Taylor said that more than one person complained that Morgan’s comments were “creating a hostile work environment.” The comments involved cursing, she said. 

Taylor said UAMS doesn’t agree with the medical board’s decision. But it respects the board and will abide by its decision, she said. 

“We’ll support him as he works to renew his license,” Taylor said.

She said UAMS investigated the complaints against Morgan and said the medical school takes any allegation seriously “and we follow up on them.”

O’Dwyer said the board issued a subpoena for Morgan’s personnel file at UAMS, where he started in 2014. 

Morgan appeared before the board on Thursday and was questioned about the complaints in the file, O’Dwyer said.

The board decided not to renew his educational license, which is a one-year license, until he completed the a three-day course for distressed physicians. 

Morgan won’t be seeing patients until he gets his license back, Taylor said. His annual salary is $878,886. Tyler said that Morgan not having his license won’t affect patient care or the Myeloma Institute.

Morgan came to UAMS in 2014 to replace Dr. Bart Barlogie, the institute’s founder, who left the post to focus on clinical care and research. The myeloma institute at UAMS is considered by many to be the leading center for myeloma treatment and research in the world, and both Barlogie and Morgan are considered two of the world’s leading researchers in the field.

Morgan, originally from Wales, was a clinician and researcher with Myeloma UK Research Centre at the Institute of Cancer Research in London.

Send this to a friend